Evidence map›Paper›PMID 26039359›Full record

ArticlePloS one2015

MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium.

Matthew F Buas, Lynn Onstad, David M Levine, Harvey A Risch, Wong-Ho Chow, Geoffrey Liu, Rebecca C Fitzgerald, Leslie Bernstein, Weimin Ye, Nigel C Bird and 11 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Association of miRNA biosynthesis genesBioscience reports · 2018
    Pooled it
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Systems toxicology meta-analysis ofToxicology research · 2017
    Article
  11. Etiology and Prevention of Esophageal Cancer.Gastrointestinal tumors · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 16 institutions in 5 countries.

Matthew F BuasDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Lynn OnstadDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
David M LevineDepartment of Biostatistics, University of Washington, School of Public Health, Seattle, Washington, United States of America.
Harvey A RischDepartment of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, United States of America.
Wong-Ho ChowDepartment of Epidemiology, MD Anderson Cancer Center, Houston, TX, United States of America.
Geoffrey LiuPharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, Ontario, Canada, M5G 2M9.
Rebecca C FitzgeraldMedical Research Council (MRC) Cancer Cell Unit, Hutchison-MRC Research Centre and University of Cambridge, Cambridge, United Kingdom.
Leslie BernsteinDepartment of Populations Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California, United States of America.
Weimin YeDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Nigel C BirdDepartment of Oncology, Medical School, University of Sheffield, Sheffield, United Kingdom.
Yvonne RomeroDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, United States of America; The Romero Registry, Mayo Clinic, Rochester, Minnesota, United States of America.
Alan G CassonDepartment of Surgery, University of Saskatchewan, Saskatoon, SK, Canada.
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, California, United States of America; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, California, United States of America.
Nicholas J ShaheenDivision of Gastroenterology and Hepatology, University of North Carolina School of Medicine, University of North Carolina, Chapel Hill, North Carolina, United States of America.
Anna H WuDepartment of Preventive Medicine, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California, United States of America.
Marilie D GammonDepartment of Epidemiology, University of North Carolina School of Public Health, Chapel Hill, North Carolina, United States of America.
Brian J ReidDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.
Laura J HardieDivision of Epidemiology, University of Leeds, Leeds, United Kingdom.
Ulrike PetersDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Epidemiology, University of Washington, School of Public Health, Seattle, Washington, United States of America.
David C WhitemanCancer Control, QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Thomas L VaughanDivision of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America; Department of Epidemiology, University of Washington, School of Public Health, Seattle, Washington, United States of America.
Fred Hutch Cancer Center · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USCity of Hope · USKaiser Permanente · USKarolinska Institutet · SEMayo Clinic in Florida · USMedical Research Council · GBOntario Institute for Cancer Research · CAQIMR Berghofer Medical Research Institute · AUThe University of Texas MD Anderson Cancer Center · USUniversity of Leeds · GBUniversity of Saskatchewan · CAUniversity of Sheffield · GBUniversity of Southern California · USYale University · US

Funding

Developing Data-Driven Cancer ResearchersT32CA009168 · NCI · UNIVERSITY OF WASHINGTON · PI STEPHEN M SCHWARTZ, MICHAEL Chiao-An WU · 1985 to 2026
$10.1M
Barrett's and Esophageal Adenocarcinoma Genetic Susceptibility Study (BEAGESS)R01CA136725 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L, WHITEMAN, DAVID C · 2009 to 2011
$7.8M
ESTABLISHED INVESTIGATOR AWARD IN CANCER PREVENTION AND CONTROLK05CA124911 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI VAUGHAN, THOMAS L · 2007 to 2016
$1.6M
Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative TherapyK24DK100548 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SHAHEEN, NICHOLAS J · 2013 to 2017
$896k
Medical Research Council MC_UU_12022/2NCI NIH HHS K05 CA124911NCI NIH HHS R01 CA136725NCI NIH HHS T32 CA009168NIDDK NIH HHS K24 DK100548
6 · The paper itself

Abstract

Incidence of esophageal adenocarcinoma (EA) has increased substantially in recent decades. Multiple risk factors have been identified for EA and its precursor, Barrett's esophagus (BE), such as reflux, European ancestry, male sex, obesity, and tobacco smoking, and several germline genetic variants were recently associated with disease risk. Using data from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON) genome-wide association study (GWAS) of 2,515 EA cases, 3,295 BE cases, and 3,207 controls, we examined single nucleotide polymorphisms (SNPs) that potentially affect the biogenesis or biological activity of microRNAs (miRNAs), small non-coding RNAs implicated in post-transcriptional gene regulation, and deregulated in many cancers, including EA. Polymorphisms in three classes of genes were examined for association with risk of EA or BE: miRNA biogenesis genes (157 SNPs, 21 genes); miRNA gene loci (234 SNPs, 210 genes); and miRNA-targeted mRNAs (177 SNPs, 158 genes). Nominal associations (P<0.05) of 29 SNPs with EA risk, and 25 SNPs with BE risk, were observed. None remained significant after correction for multiple comparisons (FDR q>0.50), and we did not find evidence for interactions between variants analyzed and two risk factors for EA/BE (smoking and obesity). This analysis provides the most extensive assessment to date of miRNA-related SNPs in relation to risk of EA and BE. While common genetic variants within components of the miRNA biogenesis core pathway appear unlikely to modulate susceptibility to EA or BE, further studies may be warranted to examine potential associations between unassessed variants in miRNA genes and targets with disease risk.

Indexed as

Polymorphism, Single NucleotideAdenocarcinomaAgedBarrett EsophagusCase-Control StudiesEsophageal NeoplasmsEsophagusFemaleGastroesophageal RefluxGene Expression RegulationGenetic LociGenome-Wide Association StudyHumansMaleMicroRNAsMiddle AgedMicroRNAs

Identifiers

PMID26039359
PMCPMC4454432
OpenAlexW2156839753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.